29
Fri, Mar
51 New Articles

Kinstellar Advises Neuraxpharm on European Expansion

Kinstellar Advises Neuraxpharm on European Expansion

Deals and Cases
Tools
Typography
  • Smaller Small Medium Big Bigger
  • Default Helvetica Segoe Georgia Times

Kinstellar has advised Neuraxpharm Group on the acquisition of Farmax from SVUS Pharma in the Czech Republic, Slovakia, and Hungary. BBH reportedly advised SVUS Pharma on the sale.

The terms of the transaction were not disclosed.

Farmax, located in Hradec Kralove, Czech Republic, is a central nervous system (CNS)specialty pharmaceutical company and a distributor of both branded and non-branded generics pharmaceuticals for CNS disorder in the Czech Republic, Slovakia, and Hungary. Farmax will be renamed Neuraxpharm Bohemia and will commercialize its products under the Neuraxpharm brand. 

Neuraxpharm Group is a European specialty pharmaceutical company focused on the treatment of CNS disorders, and it is a part of the APAX portfolio group of companies.

Kinstellar’s team was led by Partner Lukas Sevcik and included Senior Associates Tereza Naucova and Adam Nemec, Associate Martin Holub, and Junior Associates Michal Matous, Tereza Maskova, and Vaclav Kment.

Editor’s Note: After this article was published BBH confirmed its involvement in the deal. The team was led by Partner Tomas Sedlacek, assisted by Senior Associate Alice Nytrova and Associate Ondrej Stanek.

Hungary Knowledge Partner

Nagy és Trócsányi was founded in 1991, turned into limited professional partnership (in Hungarian: ügyvédi iroda) in 1992, with the aim of offering sophisticated legal services. The firm continues to seek excellence in a comprehensive and modern practice, which spans international commercial and business law. 

The firm’s lawyers provide clients with advice and representation in an active, thoughtful and ethical manner, with a real understanding of clients‘ business needs and the markets in which they operate.

The firm is one of the largest home-grown independent law firms in Hungary. Currently Nagy és Trócsányi has 26 lawyers out of which there are 8 active partners. All partners are equity partners.

Nagy és Trócsányi is a legal entity and registered with the Budapest Bar Association. All lawyers of the Budapest office are either members of, or registered as clerks with, the Budapest Bar Association. Several of the firm’s lawyers are admitted attorneys or registered as legal consultants in New York.

The firm advises a broad range of clients, including numerous multinational corporations. 

Our activity focuses on the following practice areas: M&A, company law, litigation and dispute resolution, real estate law, banking and finance, project financing, insolvency and restructuring, venture capital investment, taxation, competition, utilities, energy, media and telecommunication.

Nagy és Trócsányi is the exclusive member firm in Hungary for Lex Mundi – the world’s leading network of independent law firms with in-depth experience in 100+countries worldwide.

The firm advises a broad range of clients, including numerous multinational corporations. Among our key clients are: OTP Bank, Sberbank, Erste Bank, Scania, KS ORKA, Mannvit, DAF Trucks, Booking.com, Museum of Fine Arts of Budapest, Hungarian Post Pte Ltd, Hiventures, Strabag, CPI Hungary, Givaudan, Marks & Spencer, CBA.

Firm's website.

Our Latest Issue